- Home
- EXEL vs HBANL Comparison
EXEL vs HBANL Comparison
Compare EXEL & HBANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- HBANL
- Stock Information
- Founded
- EXEL 1994
- HBANL N/A
- Country
- EXEL United States
- HBANL United States
- Employees
- EXEL N/A
- HBANL 20242
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- HBANL Major Banks
- Sector
- EXEL Health Care
- HBANL Finance
- Exchange
- EXEL Nasdaq
- HBANL Nasdaq
- Market Cap
- EXEL 10.4B
- HBANL N/A
- IPO Year
- EXEL 2000
- HBANL N/A
- Fundamental
- Price
- EXEL $40.40
- HBANL $26.05
- Analyst Decision
- EXEL Buy
- HBANL
- Analyst Count
- EXEL 22
- HBANL 0
- Target Price
- EXEL $44.00
- HBANL N/A
- AVG Volume (30 Days)
- EXEL 2.3M
- HBANL N/A
- Earning Date
- EXEL 10-28-2025
- HBANL N/A
- Dividend Yield
- EXEL N/A
- HBANL N/A
- EPS Growth
- EXEL 81.76
- HBANL N/A
- EPS
- EXEL 2.08
- HBANL N/A
- Revenue
- EXEL $2,230,005,000.00
- HBANL N/A
- Revenue This Year
- EXEL $9.19
- HBANL N/A
- Revenue Next Year
- EXEL $12.54
- HBANL N/A
- P/E Ratio
- EXEL $19.56
- HBANL N/A
- Revenue Growth
- EXEL 10.73
- HBANL N/A
- 52 Week Low
- EXEL $25.17
- HBANL N/A
- 52 Week High
- EXEL $49.62
- HBANL N/A
- Technical
- Relative Strength Index (RSI)
- EXEL 61.90
- HBANL 60.03
- Support Level
- EXEL $38.37
- HBANL $26.00
- Resistance Level
- EXEL $40.78
- HBANL $26.19
- Average True Range (ATR)
- EXEL 1.01
- HBANL 0.24
- MACD
- EXEL 0.41
- HBANL 0.03
- Stochastic Oscillator
- EXEL 91.65
- HBANL 83.66
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About HBANL Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
Huntington is a regional US bank with around $208 billion in assets and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.